Nandini Makwana

Nandini Makwana

Auto-generated profile, based on publicly available information

Nandini Makwana

NCARD, University of Western Australia, Shenton Park, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Bioorganic Chemistry
Verified
Journal Article
Closed access
RSRahul Suryawanshi
Rahul Suryawanshi
SJSushama Jadhav
Sushama Jadhav
NMNandini Makwana
Nandini Makwana
DDDipen Desai
Dipen Desai
DCDevidas Chaturbhuj
Devidas Chaturbhuj
SKSmita Kulkarni
Smita Kulkarni

1 November 2011 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MVMurugesan Vanangamudi
Murugesan Vanangamudi
VTVinay S. Tiwari
Vinay S. Tiwari
RSReshu Saxena
Reshu Saxena
RTRajkamal Tripathi
Rajkamal Tripathi
RPRamesh Paranjape
Ramesh Paranjape
SKSeturam B. Katti
Seturam B. Katti

1 June 2014 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MVMurugesan Vanangamudi
Murugesan Vanangamudi
NMNandini Makwana
Nandini Makwana
RSRahul Suryawanshi
Rahul Suryawanshi
RSReshu Saxena
Reshu Saxena
RTRajkamal Tripathi
Rajkamal Tripathi
SKSeturam B. Katti
Seturam B. Katti

3 July 2017 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
NMNandini Makwana
Nandini Makwana
BFBree Foley
Bree Foley
SFSonia Fernandez
Sonia Fernandez
SLSilvia Lee
Silvia Lee
AIAshley Irish
Ashley Irish
Patricia PricePatricia Price
Patricia Price
Cytomegalovirus (CMV) is a common opportunistic infection encountered in renal transplant recipients (RTRs) and may be reactivated without symptoms at any time post‐transplant. We describe how active and latent CMV affect T‐cell subsets in RTRs who are stable on maintenance therapy. T‐cell responses to CMV were assessed in RTRs (n = 54) >2 years post‐transplant, and healthy controls (n = 38). Seven RTRs had CMV DNA detectable in plasma. CMV antibody and DNA aligned with increased proportions of CD8+ T cells and reduced CD4/CD8 ratios. This paralleled an expansion of effector memory T‐cell (TEM), terminally differentiated T‐cell (TEMRA) and CD57+ TEMRA cell populations. Expression of NK‐cell receptors, LIR‐1 and KLRG1 on CD4+ and CD8+ CD57+ TEM and TEMRA cells correlated with elevated interferon‐γ and cytotoxic responses to anti‐CD3 and increased cytotoxic responses to CMV phosphoprotein (pp) 65 in RTRs who carried CMV DNA. CD8+ T cells from all CMV seropositive RTRs responded efficiently to CMV immediate early (IE) ‐1 peptides. The data show that latent and active CMV infection can alter T‐cell subsets in RTRs many years after transplantation, and up‐regulate T‐cell expression of NK‐cell receptors. This may enhance effector responses of CD4+ and CD8+ T cells against CMV.

26 September 2016 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
NMNandini B. Makwana
Nandini B. Makwana
BFBree Foley
Bree Foley
SLSilvia Lee
Silvia Lee
SFSonia Fernandez
Sonia Fernandez
AIAshley Irish
Ashley Irish
Patricia PricePatricia Price
Patricia Price

13 January 2019 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
SLSilvia Lee
Silvia Lee
MDMariam Doualeh
Mariam Doualeh
JAJacquita S. Affandi
Jacquita S. Affandi
NMNandini Makwana
Nandini Makwana
AIAshley Irish
Ashley Irish
Patricia PricePatricia Price
Patricia Price